Efforts to explore novel biomarkers for early-stage HCC detection, such as AFP-L3 [10], des-gamma-carboxy prothrombin (DCP) [10], and DNA methylation markers (DMMs), are ongoing [11,12]. Here, AFP is linked to hepatocellular carcinoma.